A Clearinghouse for Information about Blood Clots (DVT/)PE) and Clotting Disorders (thrombophilia) provided as a public service by the University of North Carolina Blood Research Center

Tag: Fondaparinux

  • Arixtra (Fondaparinux), Generic

    “Is the generic version of Arixtra as safe and effective as brand Arixtra?”  Answer: “Yes”. The FDA evaluated and approved generic fondaparinux made by Dr. Reddy’s Laboratories Ltd. on July 11, 2011

  • Arixtra (Fondaparinux), Generic

    “Is generic Arixtra as safe and effective as brand Arixtra?” a patient asks.  Answer: Yes. Generic fondaparinux made by Dr. Reddy’s Laboratories Ltd. was approved by the FDA on July 11, 2011

  • LMWH Injections – Making it Easier: Insuflon Ports

    Once or twice daily injections of s.c. anticoagulants for prolonged periods of time can be bothersome and unacceptable for the patient. Use of a once weekly exchanged s.c. port, called Insuflon, can make longer-term s.c. anticoagulant therapy easier and more tolerable.

  • Low Molecular Weight Heparins – Osteoporosis?

    Occasionally, a patient is treated with long-term low molecular weight heparin (LMWH) (enoxaparin = Lovenox®; Dalteparin = Fragmin®; Tinzaparin = Innohep®) . LMWH may be given because the patient (a) tolerated warfarin poorly (widely fluctuating INRs; significant side-effects, such as marked hair loss or fatigue), (b) had a recurrent thrombotic event which occured with a therapeutic INR, or…

  • HIT = Heparin-induced Thrombocytopenia

    What Is HIT? Heparin-induced thrombocytopenia (HIT) is a serious side effect that may occur when you are being treated with heparin. It may lead to low blood platelet counts and to life-threatening blood clots.